Finance

Lists
MYCOF:OTCMKTS
Noveris Health Sciences Inc
0,73 $
0,00%
(0,00) 1D
4 там., 12:48:07 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MYCOF...
Mkt. cap
3,53 млн
Avg. vol.
0,00
Volume
0,00
52-wk high
2,04 $
52-wk low
0,10 $
Beta
10,42
Shares outstanding
58,55 млн
No. of employees
3
Mkt. cap
3,53 млн
Avg. vol.
0,00
Volume
0,00
52-wk high
2,04 $
52-wk low
0,10 $
Beta
10,42
Shares outstanding
58,55 млн
No. of employees
3
News stories
From web sources and news partners
About Noveris Health Sciences Inc
CEO-
Employees3
Founded2013
HeadquartersВанкувер, Британдық Колумбия, Канада
SectorPharmaceutical industry
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-40,14 мың
-
-
32,79 мың
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-70,57 мың
5,04 мың
316,29 м.
669,62 м.
Operating expense
-110,70 м.
5,04 мың
316,29 м.
702,42 м.
Total operating expenses
-110,70 м.
5,04 мың
316,29 м.
702,42 м.
Operating income
110,70 м.
-5,04 мың
-316,29 м.
-702,42 м.
Other non operating income
85,53 мың
-417,63 м.
-1,32 млн
640,56 м.
EBT including unusual items
73,79 мың
3,16 млн
-1,62 млн
22,81 мың
EBT excluding unusual items
73,79 мың
-405,27 м.
-1,62 млн
-155,29 м.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
73,79 мың
3,16 млн
-1,62 млн
22,81 мың
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-26,16 мың
-12,63 мың
-9,90 мың
Net interest expenses
-
-26,16 мың
-12,63 мың
-9,90 мың
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары